More Fields

Filters

Profiles which have:

Recent Changes

Profiles with recent changes to:
Sign up to Download

1-3 of 3 results

  • viracta.com
  • 1
  • 1
  • 33
We are a precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide. Our lead product candidate is Nana-val, an all-oral combination therapy of our proprietary investigational drug,..
Relevance: 105.717255
  • ebvlymphoma.com
  • 1
  • 1
EBV exists in a latent form in tumor cells. In that form, it is not susceptible to the cytotoxic activity of ganciclovir... Nanatinostat induces EBV lytic activation and expression of the EBV BGLF4 protein kinase (the "Kick")... Identifying which..
Relevance: 101.48183
  • www.viracta.com
  • 1
  • 1
  • 32
This year we are poised to deliver a steady cadence of anticipated catalysts, including updates from NAVAL-1 and complete dose escalation data from our advanced EBV+ solid tumor study. With these and other milestones ahead of us and a cash runway..
Relevance: 28.337255